Figure 1. Rosuvastatin reduced mortality and prevented body temperature loss in sepsis mice. Mice were divided into four groups: control, Rosuvastatin, LPS, and LPS+Rosuvastatin (15 mice/group). (A) Percent survival of experimental mice; (B) Body temperature (n=8, **, P<0.01 vs. control group; #, P<0.05 vs. LPS group).